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Abstract
Although previous research has demonstrated the key role of the oocyte-derived factors,
bone morphogenetic protein (BMP) 15 and growth differentiation factor (GDF) 9, in follicular
development and ovulation, there is a lack of knowledge on the impact of external factors,
which females are exposed to during folliculogenesis, on their expression. The present
study investigated the effect of the aphrodisiac Tribulus terrestris on the GDF9 and BMP15
expression in the oocytes and cumulus cells at mRNA and protein levels during folliculogen-
esis in two generations of female rabbits. The experiment was conducted with 28 New Zea-
land rabbits. Only the diet of the experimental mothers group was supplemented with a dry
extract of T. terrestris for the 45 days prior to insemination. The expression of BMP15 and
GDF9 genes in the oocytes and cumulus cells of mothers and F1 female offspring was ana-
lyzed using real-time polymerase chain reaction (RT-PCR). The localization of the GDF9
and BMP15 proteins in the ovary tissues was determined by immunohistochemical analy-
sis. The BMP15 and GDF9 transcripts were detected in the oocytes and cumulus cells of
rabbits from all groups. T. terrestris caused a decrease in the BMP15 mRNA level in the
oocytes and an increase in the cumulus cells. The GDF9mRNA level increased significantly
in both oocytes and cumulus cells. The downregulated expression of BMP15 in the treated
mothers’ oocytes was inherited in the F1 female offspring born to treated mothers. BMP15
and GDF9 show a clearly expressed sensitivity to the bioactive compounds of T. terrestris.
Introduction
The plant, Tribulus terrestris (TT), is used in the industrial production of medical preparations
and feed additives based on its saponin fraction [1]. The dry extract of TT is extremely rich in
substances having potential biological significance, such as flavonoids, alkaloids [2], glycosides,
and phytosteroids [3–5]. Since ancient times, T. terrestris is known as an aphrodisiac herb with
stimulating effects on the androgenic metabolism in humans and male animals [6–11]. Recent
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studies show that this plant can also influence female reproduction and improve female sexual
dysfunction [12]. Oral treatment of aqueous extracts of TT increases the number of growing
follicles in mice, but without significant effect on the sex hormone levels [13]. The increase in
egg production in Guinea fowls treated with TT extract report [14]. [15] showed higher num-
bers of yellow bodies in the ovaries of treated immature rats as an evidence of LH-like activity
of TT, causing puberty onset. Moreover, TT was suggested as an alternative treatment for poly-
cystic ovary disease. A high dose of the extract can efficiently remove ovarian cysts and resume
ovarian activity [16–17]. It seems that TT affects folliculogenesis in females; however, limited
information is available in this regard and the mechanisms underlying the action of TT remain
unknown.
It is well known that two oocyte-specific genes, growth differentiation factor 9 (GDF9) and
bone morphogeneticprotein 15 (BMP15), play a key role in the regulation of folliculogenesis in
many species. These factors induce the proliferation and differentiation of the follicular cells
during follicular development from the primordial stage [18–19]. In addition, they are involved
in the final events of maturation and ovulation, such as cumulus cell expansion and yellow
body formation [20–22]. For efficient female fertility, a precisely balanced level of BMP15 and
GDF9 expression in oocytes is required [23]. These processes are controlled and coordinated
by mutually dependent actions between oocytes and cumulus cells [24]. Evidence of the impor-
tance of BMP15 and GDF9 in female fertility was obtained through experiments with knockout
and transgenic animals [25–27], analyses of the gene mutations in ewes and humans [28–31],
as well as through in vitro experiments with oocytes-cumulus complexes [32–34]. However,
there is a lack of knowledge on how external factors affect the expression of these oocyte-
derived growth factors, particularly the nutritional factors that animals are exposed to during
folliculogenesis.
There are only few in vivo studies available in this field. A previous study [35], showed that
a 40% calorie restriction in mice led to a decline in the expression of GDF9 in the ovaries; how-
ever, a contrasting data was provided by another study [36]: no differences were observed in
the GDF9 and BMP15 mRNA levels in the oocytes of ewes exposed to the high and low energy
diets for two weeks before superovulation. In rabbits, a previous study [37] examined the effect
of moderate and severe dietary feed restriction (21 days), followed by refeeding (8 days), on
GDF-9 gene expression in mature and immature oocytes. They established an enhanced per-
centage of mature oocytes, accompanied by a significant increase in GDF-9-mRNA levels in
oocytes after refeeding. In contrast, another study [38] did not observe any change in the
mRNA levels of GDF9 and BMP15 from whole ovaries of rabbits fed on a high fat, high choles-
terol diet.
Considering the pivotal role of the paracrine factors GDF9 and BMP15 in folliculogenesis
from the primordial stage until ovulation, we hypothesize that the biological active compounds
of TT affect their expression through metabolic pathways. To test this hypothesis, we aimed to
evaluate the growth factors, GDF9 and BMP15, at mRNA and protein levels to determine: a)
how TT affects folliculogenesis and ovulation rates in rabbit-mothers and b) how TT impacts
the ovaries of F1 female offspring born to the treated mothers.
Materials and Methods
Experimental design for animals
The investigations were conducted with 28 female white New Zealand rabbits in the animal
facility of the Institute of Biology and Immunology of Reproduction, Sofia, Bulgaria. The
experiment started with 14 sexually mature does (mothers generation) randomly divided in the
control and experimental groups of 7 females each. The animals from the experimental group
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were individually provided the feed additive, VemoHerb-T (VHT, producer Vemo-Ltd, Bul-
garia), with their drinking water, in daily doses of 3.5 mg/kg body weight for 45 days prior to
insemination. The VHT preparation contained a dry extract of Tribulus terrestris with the fol-
lowing active substances: 60% furostanol saponins, determined as protodioscin; flavonoids—
10.0%; tannic compounds—tannin—10.0%. Both groups were fed with standard diet for
mature rabbits. At the end of the experimental period, female rabbits from both groups were
mated with one control male rabbit. The number and survivability of offspring were estimated.
The animals from the parental generation were slaughtered, after weaning of the offspring, for
ovary collection.
Among the female newborns (F1 female generation), two new groups were formed, control
and experimental, of 7 females each to the origin from the mothers’ generation. The animals
were fed standard diet and kept in the same conditions as the mothers’ generation, but without
VHT additive, until puberty onset (6 months old) and were slaughtered thereafter for ovary
collection.
All animals were reared and handled in accordance with the Bulgarian Veterinary Law (25/
01/2011), in terms of the life conditions and welfare of experimental animals, adapted to the
European Union regulation 86/609. In accordance with the Bulgarian Veterinary Law (Regula-
tion N20 /01.11.2012 based on the Directive 2010/63/EU on the protection of animals used for
scientific purposes in the Member States), only the National Ethics commission for animals
can approve the use of animas for scientific purposes. The present study is one of the planned
institutional projects for the period 2013–2018 and its protocol has been approved by the
National Ethics commission for animals within the delivered permission of use of the animals
in the experiments" (N84/04.10.2013, expiry date 04.10.2018). The responsible person for ani-
mal welfare at the Institute, working directly with the animals, is licensed by Bulgarian veteri-
nary services for animal experimentation. The slaughtering of animals was performed after
previously anesthetizing with 2% xylazine. All efforts were made to minimize suffering.
Sample collection
Ovaries removed from the slaughtered animals were kept in PBS and brought to the laboratory
immediately. One ovary from each animal was used for the collection of oocytes and cumulus
cells. The cumulus-oocyte complexes (COCs) were aspirated by puncturing the follicles (diam-
eter2 mm) and collected under the stereomicroscope SMZ-10 (Nikon, Japan). Firmly com-
pacted COCs with multilayered cumulus cells and a uniformly granulated cytoplasm were
separated into oocytes and cumulus cells by repeated aspiration using a narrow-bore Pasteur
pipette. Final denudation of the oocytes was performed by hyaluronidase treatment (Sigma-
Aldrich; at a working concentration of 300 μg/mL), followed by washing thrice in PBS. The col-
lected samples were stored at -80°C until RNA extraction.
Extraction and Purification of Total RNA and First-strand cDNA
Synthesis
Total RNA was isolated from cumulus cells and oocytes separately for each animal, using a
commercial RNA purification kit (NORGEN, 17200, Canada). A 1-μL volume of the solution
was used for a concentration test and examination of the RNA integrity with a Qubit RNA
Assay Kit (Invitrogen, Q32852). The extracted RNA was kept at –70°C.
The first strand of cDNAs was synthesized by the kit “Easy Script Plus Reverse Transcripta-
se“(G177, abm, Canada), according to the manufacturer’s instructions using the oligo dT and
random primers mix included in the kit.
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Real Time PCR
The analysis of the GDF9 and BMP15 gene expressions in oocytes and cumulus cells was per-
formed by RT-PCR using two sets of primers, GDF9-forward primer: 50-AAAGACCAGCTGC
AGCATCC-30and reverse primer: 50-TGGTGTGAACTGGAGAGCCA-30; BMP15-forward
primer: 50-GCTGGGATCACTGGATCATT-30 and reverse primer: 50- TGTACAGGACTGGGC
AATCA -30. All primers were commercially synthesized (Sigma-Aldrich, USA).
PCR amplification was performed under the following conditions: predenaturation at 95°C
for 10 min; 40 cycles for each sample that comprised an initial denaturation step at 95°C for 5 s,
annealing at 60°C for 20 s, and extension at 60°C for 30 s. Rabbit glyceraldehyde-3-phosphate
dehydrogenase (GAPDH- forward primer: AAGGTCATCCACGACCACTT; GAPDH- reverse
primer: AGGCCATGCCAGTGAGT; Sigma-Aldrich, USA) was used as a control gene for PCR.
At the same time, negative controls (without cDNA template), with cDNA substituted for water,
were set up for comparison. Each sample was run in triplicate. The cycle threshold values (CT)
indicated the quantity of the target gene in each sample and the sequence of the target gene was
determined in realtime using an Mx3005P QPCR system (Stratagene, LaJolla, CA, USA).
In order to correct the inter-run fluctuations, standard curves were generated for each gene
by serial dilution of the mix cDNA samples (1, 1:5, 1:25, 1:125, 1:625, and 1:3125). A 2-μL vol-
ume of each concentration was used as a sample separately for the construction of GDF9,
BMP15, and GAPDH gene standard curves.
Immunohistochemistry
The second ovary of each animal was fixed with 10% formaldehyde PBS and subsequently
dehydrated and embedded in paraffin. Serial sections of 5-μm thickness were cut by using a
microtome type 2125RT (Leica GmbH, Germany). The histological estimation of the folliculo-
genesis was done by counting the number of the different classes of follicles per μm.
For the detection and analysis of GDF9 and BMP15 proteins, the immunohistochemical
technique described by [39] was performed using commercial antibodies. Simultaneously,
immunohistochemical-negative controls were carried out using an irrelevant IgG. Briefly, sec-
tions were blocked with 3% hydrogen peroxide for 15 min and kept in 10% donkey serum for 1
h at room temperature. The primary antibodies goat polyclonal anti-human, in working dilu-
tion GDF-9 1:100 or BMP15 1:100 (GDF9, code sc-12244; BMP15, code sc- 18337, Santa Cruz
Biotechnology, Inc.; Santa Cruz, CA, U.S.A.) were used for incubation over night at 4°C. The
primary antibody reaction was achieved using donkey anti-goat biotinylated secondary anti-
bodies in a working dilution of 1:200 (code sc-2023) for 1 h, followed by avidin-biotin complex
(1:1000; code PK-6100, Vector, USA) for 1 h. Finally, the binding was visualized by the addi-
tion of 3,30-diaminobenzidine (DAB) chromogen solution (1:200; code SK-4105, Vector, USA)
for 10 min. After counterstaining with hematoxylin (Vecto, USA), the sections were observed
with an Olympus BX51 (Olympus, Tokyo, Japan) and images were taken with a Powershot G6,
7.1 megapixels digital camera (Canon Inc., Japan).
Statistical Analysis
Depending on the sample number and normality of distribution, parametric and non-paramet-
ric statistics were used. For n> 30 and normal distributions, Student’s t-test was applied. In all
other cases, the Wilcoxon rank-sum test was used to estimate the significance of results.
The data from PCR were developed by DataAssist Sft. (Ver. 3. 01, Applied Biosystems)
using the ΔCt method [40]. The quantifying results of copy numbers of BMP15 and GDF9
mRNA were expressed as a mean of the ratio of target genes to the control gene—GAPDH. For
the evaluation of the feed additive effect, the ΔΔCt method was applied for the comparison
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between the control and the experimental groups [40]. The fold change (FC) against the con-
trol group 2 and p value 0.05 were considered as an up-regulation; FC 0.5 and p 0.05
were considered as downregulation. Genes with a FC between 0.5 and 2 were considered to
indicate no significant change.
The immunostaining reaction was evaluated on representative fields of the ovary slices.
Immunoreactivity of GDF9 and BMP15 was assessed as a percent of the staining intensity of
the positive cells inside a defined area (μm2), using the software program ImageJ. A t-test was
used to compare the results between control and experimental groups. Statistical significance
was set at p< 0.05.
Results
Supplementation of VHT in the rabbit mothers’ diet led to an increase in ovary weight in both
generations of female rabbits. VHT did not affect fertility; the number of offspring born was
similar to that of the control group (S1 Table). However, the survivability of newborns of
treated mothers was higher than that of the control group (S1 Fig). The density of the primary
and secondary follicles in the ovaries of the treated mothers’ generation and the density of the
preantral follicles in the ovaries of F1 females born to the treated mothers were higher than
those in the controls (S2 Table).
In the oocytes and cumulus cells collected from all does, both BMP15 and GDF9 transcripts
were detected. There were the differences in the expression of the investigated genes between
generations. BMP15 and GDF9 expression in the oocytes of control F1 females’ ovaries was
higher than that in the control mothers’ ovaries (Fig 1A). A remarkable difference was
observed in the expression of GDF9; the mRNA level of GDF9 in the oocytes of the F1 genera-
tions’ ovaries was several times higher than those in the mothers’ ovaries. In contrast, the
expression of BMP15 and GDF9 in the cumulus cells of rabbit-mothers’ ovaries and F1 females
was not significantly different (Fig 1B).
Supplementation of the rabbit-mothers’ diet with the feed additive VHT led to a decrease in
the BMP15 mRNA level in the oocytes and an increase in its level in the cumulus cells (Fig
2A). The significant increase in GDF9 mRNA levels in both oocytes and cumulus cells was
observed in the ovary of mothers treated with VHT (Fig 2C).
Fig 1. mRNA level of GDF9 and BMP15 in the oocytes (A) and cumulus cells (B) of the female rabbits in dependence on age. The results were
obtained by comparison of the control groups from both generations–does-mothers and F1 female offspring. Total RNA was extracted from the oocytes and
cumulus cells and subjected to real-time PCR to determine the mRNA levels of BMP15 and GDF9. The expression of these mRNAs was normalized to the
expression of control gene GAPDH. The triplicates for each reaction were averaged. This data represent the mean ±SEM of the combined results from the
analysis of seven rabbits from each group (*, P < 0.05). The significantly higher expression of BMP15 and GDF9 in the oocytes from the ovaries of F1 female
compared to the mothers' generation was observed.
doi:10.1371/journal.pone.0150400.g001
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The expression level of mRNA in the investigated genes was lower in both oocytes and
cumulus cells in the ovaries of F1 females’ offspring born to experimental mothers compared
to the F1 females born to the controls (Fig 2B and 2D). We noticed down-regulation of
BMP15 in oocytes of the offspring (FC = 0.12, P< 0.05) and GDF9 in cumulus cells
(FC = 0.25, P< 0.05).
The direct effect of the VHT supplementation on the expression of BMP15 and GDF9 genes
in the oocytes and cumulus cells of the treated mothers was several times higher than that in
the F1 female offspring born to them (Table 1).
Both the investigated genes demonstrated sensitivity to VHT treatment. However, a more
powerful impact of VHT on the GDF9 gene expression in the cumulus cells of mothers’ ovaries
was observed.
Fig 2. Effect of the VHT supplementation of rabbit mothers’ diet on the expression of BMP15 and GDF9mRNA levels in the oocytes and cumulus
cells of two generations. (A) and (C) mothers’ generation; (B) and (D) F1 female generation. The only experimental group of the mothers’ generation was
treated with feed additive VemoHerb-T (dry extract of plant Tribulus terrestris, producer Vemo-Ltd) during 45 days prior to insemination. Total RNA was
extracted from the oocytes and cumulus cells and subjected to real-time PCR to determine the mRNA levels of BMP15 and GDF9. The expression of these
mRNAs was normalized to the expression of control gene GAPDH. Data are shown as a relative ratio (fold change—FC) of the mRNA level of these genes in
the experimental groups to the controls of each generation. These data represent the mean ±SEM of the combined results from the analysis of seven rabbits
from each group (*- significance P < 0.05, compared to control). T. terrestris caused a decrease in the BMP15 mRNA level in the oocytes and an increase in
the cumulus cells. The GDF9mRNA level increased significantly in both oocytes and cumulus cells. The downregulated expression of BMP15 in the treated
mothers’ oocytes was inherited in the F1 female offspring born to treated mothers.
doi:10.1371/journal.pone.0150400.g002
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The localization of BMP15 and GDF9 proteins was determined by immunohistochemistry.
Immunopositive signals of BMP15 and GDF9 were detected in the oocytes and cumulus
cells of the follicles in the ovaries of mothers and F1 females’ (Figs 3 and 4) from both groups,
control and experimental. In addition, both growth factors were detected in the theca, intersti-
tial, and corpus lutein cells.
The computer estimated immune staining intensity of the investigated proteins had shown
the most intensive signals of BMP15 (Fig 5) and GDF9 (Fig 6) in the oocytes from primordial
and primary follicles and the lowest in the oocytes from antral follicles in all groups. Signifi-
cantly higher signals for both proteins were observed in the primary and secondary oocytes
from ovaries of the mothers treated with VHT. The increased secretion of GDF9 in the oocytes
from antral follicles of treated mothers’ ovaries corresponded with the results of mRNA level
changes obtained by PCR, whereas the results related to the BMP15 signals in the oocytes are
somewhat contradictory. Although the level of BMP15 mRNA in the oocytes of treated moth-
ers decreased, there were no differences in the intensity of protein signals compared to the con-
trol oocytes. It is likely that a reverse of the protein BMP15 from cumulus cells to oocytes
occurred due to a deficit in mRNA production in the oocytes. Thus, the BMP15 protein expres-
sion was significantly higher in the cumulus cells of the antral follicles in both experimental
groups F0 mothers and F1 female offspring generations (Fig 5).
In the cumulus cells, the intensity of BMP15 and GDF9 signals increased from primary to
secondary and preantral follicles and decreased again to antral follicles. The more intense
GDF9-signals were detected in the cumulus cells from the secondary follicles of the treated
mothers (Fig 6).
Discussion
Previous studies have shown that GDF9 and BMP15 have distinct effects on the reproductive
physiology in a species-specific manner [41]. Considering this, it is very important to collect
data on BMP15 and GDF9 actions in the ovaries of different animal species. To our knowledge,
our study was the first in vivo study describing the changes in the expression of the growth fac-
tors BMP15 and GDF9 at mRNA and protein level in the follicular structures of female rabbits
in two generations–mothers and F1 female offspring–as a result of supplementation of dry
extract of T. terrestris to mothers’ diet 45 days prior to insemination. The obtained data dem-
onstrated the clearly expressed sensitivity of the BMP15 and GDF9 to the bioactive compounds
of T. terrestris.
T. terrestris is one of the most popular phyto-aphrodisiac for male reproduction. Although
the long-term use of this plant improves sexual performance in males, there is no consensus on
the exact mechanisms of TT action in the organism. It is believed that steroidal saponins pres-
ent in TT extracts can enhance the endogenous androgen production by increasing luteinizing
hormone release from the pituitary gland [42]. Another hypothesis proposes that TT bioactive
Table 1. The impact of VHT on the changes in BMP15 and GDF9 expression in both generations of
female rabbits (FCVHT-M/ FCVHT-F1).
Parameters oocytes cumulus cells
BMP15 2.50 6.80
GDF9 9.30 22.40
FCVHT-M and FCVHT-F1 −the fold change of gene expression relative to the control in the treated mothers
and F1 female offspring born to treated mothers. The remarkable changes in the expression of the GDF9 in
cumulus cells were noticed.
doi:10.1371/journal.pone.0150400.t001
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compounds might be enzymatically converted into weak androgens such as dehydroepiandros-
terone, which could be converted into more potent androgens such as testosterone or estradiol
in the gonads [43]. The potential application of TT as an alternative therapy for the sexual dys-
function in women [12] as well as the evidence of its ability to remove ovarian cysts [16] has
led to increased research on this plant focusing on female reproduction.
Our results show the stimulating effect of the additive VemoHerb-T on the weight of rabbit
mothers’ ovary and weight of the offspring. Similar results were observed in mice [13] and in
Guinea fowls [14] treated with the extract of TT. Moreover, the treated mother does in our
experiment expressed more pronounced maternal instincts than the controls. They more
actively prepared the nests and took thorough care of the pups. The Kaplan-Meier analysis
confirmed a higher survivability of newborns to experimental mothers. Considering that such
maternal behavioral reactions are related to the action of estrogens on the central nervous sys-
tem [44], our results indicate an enhanced level of estrogens in the ovary of treated mothers.
Our results are consistent with a previous study [42], which demonstrates an increase in the
luteinizing hormone level in female rats treated with TT. The LH-like effect of T. terrestris on
rats’ ovaries has been demonstrated in a previous study [15]. It is known that LH can stimulate
Fig 3. Immunohistochemical staining for BMP15 in the rabbit ovaries of the mothers and F1- female offspring generations. Localization of the
protein BMP15 in: (a) oocytes of the primordial and primary follicles in the VHT-treated mothers ovary; (b) granulosa cells of the tertiary follicle in the VHT-
treated mothers ovary; (c) primordial and primary follicles—negative control of antibody; (d) oocytes of primordial and primary follicles in the ovary of F1
offspring born to treated mothers; (e) oocytes and granulosa cells of the antral follicle in the ovary of F1 offspring born to treated mothers; (f) mouse testis—
positive control of antibody; (g) Original magnification: (a–f) × 20.
doi:10.1371/journal.pone.0150400.g003
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estradiol production in the ovary by the activation of the aromatase pathway [45]. An
enhanced level of estradiol was reported in women who used the preparation Tribestan (pills
containing the dry extract of TT); despite the suppression of FSH production, the secretion of
estradiol and progesterone did not decrease in women treated with Tribestan [46].
However, it is impossible to explain all morphological changes in the ovaries of experimen-
tal animals, particularly the increase in the density of secondary follicles, by the hormonal
changes only, because at this stage they are not sensitive to hormones. Similar to the present
study, an enhanced number of secondary follicles in the ovaries of TT treated rat was found in
a previous study [15]. These results can be explained on the basis of our data, which demon-
strated the changes in the expression of growth factors BMP15 and GDF9 in the oocytes and
cumulus cells under TT treatment.
Currently existing literature related to rodents mainly provides information on the expres-
sion of GDF9 and BMP15 genes in the oocytes [47, 26]. In our in vivo experiments, we estab-
lished new insights that the transcripts of BMP15 and GDF9 were detected in both oocytes and
cumulus cells in the ovaries of all adult and young rabbits. Their expression was higher in the
oocytes of young animals, whereas the expression in the cumulus cells exhibited no significant
Fig 4. Immunohistochemical staining for GDF9 in the rabbit ovaries of the mothers and F1- female offspring generations. Localization of the protein
GDF9 in: (a) oocytes of the primordial and primary follicles in the VHT-treated mothers ovary; (b) oocytes and granulosa cells of the early antral follicle in
theVHT- treated mothers ovary; (c) antral follicle- negative control of antibody; (d) oocytes of primary and primordial follicles in the ovary of F1 offspring born
to treated mothers; (e) oocyte and cumulus-granulosa cells of the antral follicle in the ovary of F1 offspring born to treated mothers; (f) mouse ovary—positive
control of antibody; (g) Original magnification: (a–f) × 20.
doi:10.1371/journal.pone.0150400.g004
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difference between the young and adults. These results correspond with the results of previous
studies on the age-associated profiles of BMP15 and GDF9. Significant BMP15 gene expression
in rabbit ovaries from 14 d post parturition were observed, when primordial follicles were
clearly detected [48]. The highest level was measured at 60 d post parturition and a lower level
Fig 5. The dynamic of BMP15 protein expression in the oocytes and cumulus cells of the follicles at
different stages of the development in rabbit ovaries. Control M–mothers generation; Control F1- female
offspring born to the control mothers; VHT-M- VemoHerb-T treated mothers; VHT-F1- female offspring born
to the treated mothers; 0-I–primordial and primary follicles; II-III–secondary and preantral follicles; IV–antral
follicles. *—significant differences, p < 0.05. Protein expression was estimated by the program ImageJ based
on the intensity of immunostaining reactions on the defined square. At least 5 slides per animal were
analysed. Significantly intensive signals were detected in the oocytes from primordial and primary follicles in
the ovaries of treated mothers as well as in the cumulus cells from the antral follicles of F1 females born to the
treated mothers.
doi:10.1371/journal.pone.0150400.g005
Tribulus terrestris and BMP15 and GDF9 in Rabbit Ovary
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Fig 6. The dynamic of GDF9 protein expression in the oocytes and cumulus cells of the follicles at
different stages of the development in rabbits ovaries.Control M–mothers generation (n = 7); Control F1-
female offspring born to the control mothers (n = 7); VHT-M- VemoHerb-T treated mothers (n = 7); VHT-F1-
female offspring born to the treated mothers (n = 7); 0-I–primordial and primary follicles; II-III–secondary and
preantral follicles; IV–antral follicles. *—significant differences, p < 0.05. Protein expression was estimated
by the program ImageJ based on the intensity of immunostaining reactions on the defined square. At least 5
slides per animal were analysed. Significantly intensive signals were detected in the oocytes from primordial,
primary and secondary follicles in the ovaries of threated mothers as well as in the oocytes from secondary
follicles of F1 females born to the treated mothers.
doi:10.1371/journal.pone.0150400.g006
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was detected in adult animals. Similar results were obtained during the investigation of gene
profiles in the oocytes from young and adult mice [49,35]. Our results confirmed the findings
of a previous study [50] that GDF9 expression is higher in the oocytes of young calves than in
adult cows. However, our results differ from the results of that study [50] in terms of age-asso-
ciated BMP15 expression in bovine oocytes and cumulus cells.
We established the presence of BMP15 and GDF9 proteins in the follicles at all stages of
development as well as in the interstitial and corpus lutein cells, which strongly suggest their
pivotal role in the whole process of folliculogenesis in rabbits and confirms the previous inves-
tigations in other rodents [27, 32].
In the present study, the alteration in the expression of the BMP15 and GDF9 genes, as a
result of the supplementation of feed additive VHT to the mothers’ diet, indicated their high
sensitivity to metabolic changes in the ovaries. These findings are consistent with those of pre-
vious studies [35, 37], in which the calorie restriction in mice, as well as the feed restriction and
refeeding in rabbits lead to changes in GDF9 expression in the ovaries. In our study, T. terres-
tris caused the alteration of mRNA levels of both genes, but in different ways. Although we
noticed a downregulation of BMP15 in the oocytes of treated mothers, we did not observe any
failure in their fertility. This corresponds with the conclusion of [32] that in rodents, BMP15 is
only partially required for ovulation and fertilization. Nevertheless, the observed increase in
BMP15 mRNA level in the cumulus cells possibly compensates the lack of BMP15 expression
in the oocytes.
Additionally, we found a significant upregulation of the GDF9 gene in the oocytes and
cumulus cells of treated mothers. GDF9 is the closest homolog to BMP15 (known as GDF9B).
Both bind to the same type II receptor, BMPRIIB, which is essential for GDF9/BMP15 signal-
ing in granulosa cells [51, 19] and show synergism or have similar activity during folliculogen-
esis [52]. Moreover, GDF9 supports embryo development and fetal viability [53]. It is likely
that these biological functions of GDF9 facilitated increased fertility in our experimental ani-
mals, despite the decreased level of BMP15 mRNA in the oocytes.
The morphological changes in the treated rabbits’ ovaries followed the changes in the
expression of growth factors. There is substantial evidence in several mammalian species that
GDF9 is essential for the early stages of follicle development [52]. The increased level of GDF9
in our study ensured a more active involvement of the ovarian reserve in the development. We
observed a higher density of primary and secondary follicles in the ovary of the mothers treated
with TT. In addition, the diameter of secondary and preantral follicles was higher than that in
controls (unpublished data). This is likely due to the ability of GDF9 to regulate granulosa cell
mitosis through both, Smad-dependent and independent signaling pathways [54].
To our knowledge, this is the first study to demonstrate that T. terrestris causes a significant
increase in GDF9 at the mRNA and protein levels in the oocytes and cumulus cells of rabbits.
These results provide additional value to the explanation of the therapeutic effect of TT
described in previous studies [12, 16] in females, because the lack of GDF9 leads to several
types of ovarian disorders. It was reported that ovaries from 25- to 31-week-old female GDF9
null mice contain either single unilateral or bilateral ovarian follicular cysts, lined by several
layers of flattened granulosa cells [25]. In addition, research on ovary tissues from women with
polycystic ovary syndrome (PCOS) revealed that GDF9 mRNA expression is substantially
delayed and reduced during the growth and differentiation phase [55] and cannot reach the
normal level even after ovarian stimulation, which is the premise for impaired oocyte quality
and developmental competence in PCOS females [56]. The increased level of GDF9 mRNA in
the ovaries of animals treated with TT should be the main reason for the success of TT in
removing ovarian cysts [16]. Additionally, the GDF9 acting in theca cells regulates androgen
production and subsequently affects granulosa cells in different ways–by facilitating granulosa
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cell estrogen production from androgen aromatization, or by ensuring direct effects of andro-
gens on granulosa cell growth through the androgen receptor that is expressed in granulosa
cells [34, 52].
If we accept the mainly discussed hypothesis that TT acts like the LH-hormone, a high level
of GDF9 is also essential for modulating the LH receptors to ensure an adequate reaction to the
hormone, because the oocyte-secreted factors, GDF9 and BMP15, have an effect on FSH and
LH through the expression of their receptors on target cells [57–59]. Therefore, the upregula-
tion of GDF9 in the oocytes and cumulus cells caused by TT explains the consequences of TT
action. However, the exact mechanism underlying the increase in GDF9 level remains unclear
and requires further investigations.
The analysis of mRNA levels of BMP15 and GDF9 in the oocytes and cumulus cells of F1
female offspring showed heritable changes in the BMP15 gene function. The down regulation
of this gene was expressed also in the oocytes of F1 females born to treated mothers. Our results
strongly suggest that rabbit’s oocytes are susceptible to epigenetic modulations during folliculo-
genesis and that the bioactive supplement VHT should be one of the factors causing this trans-
generational epigenetic effect related to BMP15. Epigenetic processes can occur due to the
direct exposure to external factors at critical periods, particularly during sensitive developmen-
tal windows for the germ cells, such as folliculogenesis [60]. Nutrition, as an environmental fac-
tor, affects oocytes. Therefore, changes in the environment surrounding oocytes can alter the
pattern of genes expressed by these structures, with consequences for both immediate and lon-
ger-term development [61]. Despite the fact that rabbits belong to a group of mammals that do
not ovulate spontaneously, it is known that follicles develop and regress in cycles of 15−16
days. It seems that the exposure of the rabbit mothers to the bioactive supplement TT during
45 days of the periconceptual period was sufficient to induce changes in the oocytes-secreted
gene BMP15. It is likely that the pathways of TT action on the investigated growth factors are
different. The upregulation of GDF9 mRNA in the oocytes and cumulus cells stimulated by TT
was not inherited in F1 females; moreover, we observed a lower level of GDF9 mRNA in the
oocytes and cumulus cells of these animals compared to the F1 females born to the control
mothers.
Conclusions
The present study provides for the first time the evidence for the stimulating effect of TT on
the expression of GDF9 and BMP15 at mRNA and protein levels in the oocytes and cumulus
cells of rabbits in two generations. The results indicate that these growth factors are sensitive to
the bioactive compounds of TT in different ways at different follicle structures. At the same
time, GDF9 and BMP15 showed their interchangeability in rabbits. Therefore, overexpression
of GDF9 in the case of BMP15 suppression ensured normal development and ovulation of the
follicles and high fertility at the first insemination after the treatment.
The present study provides insights into the therapeutic effect of the plant T. terrestris on
female reproduction at the molecular level. Further studies are required to elucidate the exact
pathways of TT action on growth factors expression, as well as on the epigenetic mechanisms
of the influence of TT on F1 female offspring.
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S1 Table. Effect of VHT supplementation to the mothers’ diet on reproductive parameters.
The experimental group of mothers was treated with the feed additive VemoHerb-T (dry
extract of the plant Tribulus terrestris, producer Vemo-Ltd) 45 days prior to insemination.
Both groups were mated with the same male rabbit. Data are presented as a mean ± SEM;
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mean ±SEM, t-test was applied, and the differences were considered significant at p< 0.05.
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S1 Fig. Kaplan-Meier analysis of the F1 offspring survivability born to control and to
mothers’ groups treated with VHT. The experimental group of mothers was treated with the
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days prior to insemination. Both groups were mated with the same male rabbit. A significantly
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